Analysts Set Azenta, Inc. (NASDAQ:AZTA) Target Price at $36.20

Azenta, Inc. (NASDAQ:AZTAGet Free Report) has been given an average rating of “Hold” by the seven research firms that are currently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and three have given a buy recommendation to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $36.60.

AZTA has been the topic of several recent analyst reports. Needham & Company LLC boosted their target price on shares of Azenta from $40.00 to $42.00 and gave the company a “buy” rating in a report on Friday. Jefferies Financial Group raised Azenta from a “hold” rating to a “buy” rating and boosted their price objective for the company from $30.00 to $38.00 in a research note on Thursday, October 30th. Evercore ISI set a $33.00 target price on Azenta and gave the company an “in-line” rating in a research report on Tuesday, August 5th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Azenta in a research note on Wednesday, October 8th. Finally, Raymond James Financial raised Azenta from a “market perform” rating to an “outperform” rating and set a $35.00 price target on the stock in a research note on Wednesday, August 6th.

Read Our Latest Analysis on AZTA

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Mechanics Financial Corp grew its holdings in Azenta by 77.6% in the second quarter. Mechanics Financial Corp now owns 870 shares of the company’s stock worth $27,000 after purchasing an additional 380 shares during the period. Bessemer Group Inc. boosted its position in shares of Azenta by 249.5% during the 3rd quarter. Bessemer Group Inc. now owns 1,017 shares of the company’s stock worth $29,000 after purchasing an additional 726 shares in the last quarter. Osaic Holdings Inc. grew its stake in shares of Azenta by 44.9% in the 2nd quarter. Osaic Holdings Inc. now owns 1,242 shares of the company’s stock valued at $39,000 after buying an additional 385 shares during the period. Farther Finance Advisors LLC grew its stake in shares of Azenta by 41.6% in the 2nd quarter. Farther Finance Advisors LLC now owns 1,371 shares of the company’s stock valued at $42,000 after buying an additional 403 shares during the period. Finally, CWM LLC increased its position in Azenta by 113.5% in the 2nd quarter. CWM LLC now owns 1,898 shares of the company’s stock valued at $58,000 after buying an additional 1,009 shares in the last quarter. 99.08% of the stock is owned by institutional investors.

Azenta Price Performance

Shares of AZTA stock opened at $36.70 on Friday. The stock has a market capitalization of $1.68 billion, a PE ratio of -15.17 and a beta of 1.65. The business’s 50 day simple moving average is $30.82 and its 200 day simple moving average is $30.41. Azenta has a one year low of $23.91 and a one year high of $55.63.

Azenta (NASDAQ:AZTAGet Free Report) last issued its quarterly earnings results on Friday, November 21st. The company reported $0.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.20 by $0.01. Azenta had a negative net margin of 18.45% and a positive return on equity of 1.35%. The firm had revenue of $159.19 million for the quarter, compared to the consensus estimate of $156.76 million. During the same quarter in the previous year, the company earned $0.18 EPS. The company’s revenue for the quarter was up 5.7% on a year-over-year basis. As a group, research analysts expect that Azenta will post 0.53 earnings per share for the current year.

Azenta Company Profile

(Get Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Further Reading

Analyst Recommendations for Azenta (NASDAQ:AZTA)

Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.